BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12971955)

  • 1. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine.
    Zollner G; Fickert P; Fuchsbichler A; Silbert D; Wagner M; Arbeiter S; Gonzalez FJ; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Oct; 39(4):480-8. PubMed ID: 12971955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
    Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
    J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
    Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
    Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.
    Chen HL; Chen HL; Yuan RH; Wu SH; Chen YH; Chien CS; Chou SP; Wang R; Ling V; Chang MH
    J Cell Mol Med; 2012 Nov; 16(11):2679-89. PubMed ID: 22564513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
    Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
    J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of drug transporters by the farnesoid X receptor in mice.
    Maeda T; Miyata M; Yotsumoto T; Kobayashi D; Nozawa T; Toyama K; Gonzalez FJ; Yamazoe Y; Tamai I
    Mol Pharm; 2004; 1(4):281-9. PubMed ID: 15981587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
    El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
    Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
    Kamisako T; Ogawa H; Yamamoto K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
    Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
    J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice.
    Wolters H; Elzinga BM; Baller JF; Boverhof R; Schwarz M; Stieger B; Verkade HJ; Kuipers F
    J Hepatol; 2002 Nov; 37(5):556-63. PubMed ID: 12399219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
    Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
    Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
    Yang F; Wang Y; Li G; Xue J; Chen ZL; Jin F; Luo L; Zhou X; Ma Q; Cai X; Li HR; Zhao L
    Br J Pharmacol; 2018 Mar; 175(5):810-829. PubMed ID: 29235094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.